In this regard, inhibiting NF-κB activation using a novel, natural product inhibitor of NF-κB has been shown to reduce autoantibody production and skin lesions in MRL/lpr/lpr mice [28], although alone it was not sufficient to prevent kidney damage. This evidence concerns the gene NFKB1 and Nephropathy.